58 results
8-K
EX-99.1
KA
Kineta Inc
31 Mar 23
Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
of public health epidemics affecting countries or regions in which Kineta has operations or does business, such as the COVID-19 pandemic; the timing
8-K
EX-99.6
ie7bvf36l3
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.2
lv5vrwz97gr5do6 2f
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
bhoj8
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.1
abhqeoq4a d37gl
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
q5a4iiwrl3
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
pa7q 1bnmsxw
10 Nov 22
Prospectus supplement
4:21pm
425
hgwrjyvtgq 71kv
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.2
m7ikm8k j6
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm